Literature DB >> 11141587

Abnormal results of liver function tests in patients with Graves' disease.

M Biscoveanu1, S Hasinski.   

Abstract

OBJECTIVE: To determine the frequency of liver dysfunction in patients with hyperthyroidism.
METHODS: We analyzed the clinical records of 30 consecutive patients with Graves' disease to identify the spectrum of abnormal results of liver function tests. The values for alkaline phosphatase (AP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma -glutamyltransferase (GGT), and total bilirubin were examined.
RESULTS: The frequencies of increased levels of AP, AST, ALT, GGT, and bilirubin in the current study group were similar to but somewhat lower than those reported in previous studies. Of the 30 study patients, 11 (37%) had at least one abnormal result of a liver function test. All 30 patients in the study had determinations of AP (not fractionated), of which 10 values (33%) were above normal (range, 124 to 283 U/L). Of the 30 patients who had determinations of AST, 5 (17%) had increased values that ranged from 36 to 71 U/L. Six of the 23 patients (26%) with determinations of ALT had increased values that ranged from 45 to 157 U/L. Of the 25 patients who had measurements of GGT, 6 had above normal results (range, 69 to 331 U/L). In addition, 2 of the 24 patients (8%) with determinations of total bilirubin had increased levels.
CONCLUSION: These findings indicate that abnormal results of liver function tests are common in patients with hyperthyroidism and make the diagnosis of concomitant, unrelated liver disease difficult until the euthyroid state has been established.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11141587     DOI: 10.4158/EP.6.5.367

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  14 in total

1.  An unusual cause of jaundice.

Authors:  P J D Owen; A Baghomian; J H Lazarus; A J Godkin
Journal:  BMJ       Date:  2007-10-13

2.  Incidence of abnormal liver biochemical tests in hyperthyroidism.

Authors:  Tiffany Y Lin; Anshula O Shekar; Ning Li; Michael W Yeh; Sammy Saab; Mark Wilson; Angela M Leung
Journal:  Clin Endocrinol (Oxf)       Date:  2017-03-09       Impact factor: 3.478

Review 3.  Consequences of dysthyroidism on the digestive tract and viscera.

Authors:  Ronald Daher; Thierry Yazbeck; Joe Bou Jaoude; Bassam Abboud
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

4.  Insulin autoimmune syndrome: a case associated with HLA-DRB1 polymorphism.

Authors:  Q Zhang; S-G Chen; C-J Sheng; X-Y Cheng; H Li; H Sheng; P Yang; C-H Qian; W-J Li; S Qu
Journal:  J Endocrinol Invest       Date:  2011 Jul-Aug       Impact factor: 4.256

5.  Prevalence of echocardiographic criteria for the diagnosis of pulmonary hypertension in patients with Graves' disease: before and after antithyroid treatment.

Authors:  J H Suk; K I Cho; S H Lee; H G Lee; S M Kim; T I Kim; M K Kim; Y K Shong
Journal:  J Endocrinol Invest       Date:  2011-03-07       Impact factor: 4.256

6.  Serum Spot 14 concentration is negatively associated with thyroid-stimulating hormone level.

Authors:  Yen-Ting Chen; Fen-Yu Tseng; Pei-Lung Chen; Yu-Chao Chi; Der-Sheng Han; Wei-Shiung Yang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

7.  Factors predicting abnormal liver function tests induced by Graves' disease alone: a retrospective cohort study.

Authors:  Ruiguo Zhang; Xun Tian; Lan Qin; Xiaoer Wei; Junqi Wang; Jie Shen
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

8.  Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment.

Authors:  Renfei Wang; Jian Tan; Guizhi Zhang; Wei Zheng; Chengxia Li
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

9.  Atypical Complications of Graves' Disease: A Case Report and Literature Review.

Authors:  Khaled Ahmed Baagar; Mashhood Ahmed Siddique; Shaimaa Ahmed Arroub; Ahmed Hamdi Ebrahim; Amin Ahmed Jayyousi
Journal:  Case Rep Endocrinol       Date:  2017-02-28

10.  Serum Levels of Follistatin Are Positively Associated With Serum-Free Thyroxine Levels in Patients With Hyperthyroidism or Euthyroidism.

Authors:  Fen-Yu Tseng; Yen-Ting Chen; Yu-Chao Chi; Pei-Lung Chen; Wei-Shiung Yang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.